Search results
Actavis Generics (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial ...
All of our products undergo thorough safety monitoring and evaluation processes at every stage of a medicine's lifecycle. Learn more.
Aug 2, 2016 · Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Allergan plc (NYSE: AGN) today announced that Teva has completed its acquisition of Allergan’s generics business (“Actavis Generics”). This strategic acquisition brings together two leading generics businesses with complementary strengths, R&D capabilities, product pipelines ...
Aug 2, 2016 · Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Allergan plc (NYSE: AGN) today announced that Teva has completed its acquisition of Allergan’s generics business (“Actavis Generics”).
Make a difference to people's health, every day. Working at Teva is not just a job, it’s so much more than that. Here, you get to spend each day helping millions of people around the world enjoy healthier lives. At the same time, you’ll be joining a dedicated team, united by the strong sense that we’re building something greater than ...
Actavis (now Allergan) | 46,698 followers on LinkedIn. We would like to invite you to follow our new Allergan page at https://www.linkedin.com/company/allergan?trk=top_nav_home.
Teva’s acquisition of Actavis will improve speed to market, introduce new market capabilities and create innovative platforms for growth, all of which will prove to be essential tools as Teva works to serve unmet medical needs in the therapeutic areas of respiratory problems, movement disorders, pain and neuro-degeneration.
A Global Integrated Pharmaceutical Company
Aug 29, 2012 · The Actavis Group is a world leader in the development, manufacture, and sale of high-quality generic pharmaceuticals. The successful integration of a number of acquisitions has helped position Actavis as the 5th largest generic pharmaceutical company in the world.
Nov 23, 2014 · Actavis anticipates that the expected permanent financing structure, consisting of a combination of new equity and debt, will support an investment grade rating and provide long-term financing flexibility.
